Ironwood Pharmaceuticals News

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in

BusinesswireApr 25 16:01 ET

Investors in Ironwood Pharmaceuticals (NASDAQ:IRWD) From Five Years Ago Are Still Down 29%, Even After 8.6% Gain This Past Week

Ideally, your overall portfolio should beat the market average. But every investor is virtually certain to have both over-performing and under-performing stocks. So we wouldn't blame long term Ironw

Simply Wall StApr 24 07:18 ET

Ironwood Pharmaceuticals: A Strong Buy on Promising Gastrointestinal Treatment Prospects and Market Expansion Opportunities

TipRanksMar 28 14:37 ET

Express News | Ironwood Pharmaceuticals Announces Results From Phase 2 Exploratory STARGAZE Trial of Apraglutide For Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease

Moomoo 24/7Mar 28 07:33 ET

Ironwood Pharmaceuticals Announces Positive Results From Its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients With Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI AGVHD)

Results up to Day 91 show that apraglutide in SR GI aGVHD was well-tolerated with an acceptable safety profile, the study's primary objective.

Business WireMar 28 07:30 ET

Ironwood Pharmaceuticals (NASDAQ:IRWD): Analysts Stay Bullish Despite Recent Stock Plunge

TipRanksMar 16 12:36 ET

Ironwood Pharmaceuticals(IRWD.US) Director Buys US$60,204 in Common Stocks

$Ironwood Pharmaceuticals(IRWD.US)$ Director Duane Jon R purchased 6,920 shares of Common Stocks on Mar 6, 2024 at an average price of $8.7 for a total value of $60,204.Source: Announcement What is st

moomoo NewsMar 8 16:45 ET

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go

BenzingaMar 7 07:18 ET

Trending Stocks Today: Lytus Technologies Holdings Shoots up 231.16% Post-Market

March 6th - US stocks trending post-market.Gainers: $Lytus Technologies Holdings(LYT.US)$ surges 231.16% to $7.65 with a turnover of $20.46 million. $SCWorx(WORX.US)$ rises 19.07% to $2.08 with a turn

moomoo NewsMar 6 18:00 ET

Ironwood Pharmaceuticals(IRWD.US) Officer Buys US$100.22K in Common Stocks

$Ironwood Pharmaceuticals(IRWD.US)$ Officer Emany Sravan Kumar purchased 10,684 shares of Common Stocks on Mar 4, 2024 at an average price of $9.38 for a total value of $100.22K.Source: Announcement W

moomoo NewsMar 6 16:50 ET

Ironwood Pharmaceuticals Is Maintained at Overweight by Wells Fargo

Ironwood Pharmaceuticals Is Maintained at Overweight by Wells Fargo

Dow JonesMar 1 13:11 ET

Express News | Wells Fargo Maintains Overweight on Ironwood Pharmaceuticals, Lowers Price Target to $14

Moomoo 24/7Mar 1 13:00 ET

Ironwood Pharmaceuticals: Strong Buy Rating on LINZESS Performance and Apraglutide Market Potential

TipRanksFeb 29 15:16 ET

Ironwood's Phase 3 Results Not a Disaster, Piper Says -- Market Talk

1248 ET - While Ironwood's Phase 3 study of apraglutide in short bowel syndrome with intestinal failure wasn't the "unfettered success that we were hoping for," analysts at Piper Sandler say the resul

WSJFeb 29 12:49 ET

12 Health Care Stocks Moving In Thursday's Intraday Session

GainersSocietal CDMO (NASDAQ:SCTL) stock rose 132.6% to $1.07 during Thursday's regular session. The company's market cap stands at $112.1 million. Enveric Biosciences (NASDAQ:ENVB) shares increased b

BenzingaFeb 29 12:32 ET

Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) released topline results from its pivotal Phase 3 STARS trial of once-weekly subcutaneous apraglutide in reducing parenteral support (PS) (drugs given by rou

BenzingaFeb 29 11:34 ET

Express News | Ironwood Pharmaceuticals Shares Are Trading Lower After the Company's Phase 3 Trial of Once-weekly Subcutaneous Apraglutide Did Not Meet Two Out of Four Key Secondary Endpoints

Moomoo 24/7Feb 29 10:45 ET

Ironwood Plunges Nearly 40% After SBS Trial Misses Secondary Goals

Seeking AlphaFeb 29 10:30 ET

Ampio Pharmaceuticals, Ironwood, Incannex Among Healthcare Movers

Seeking AlphaFeb 29 10:00 ET

Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts

After moving lower in the premarket session, US stocks reversed course and looked set to open higher Thursday as investors reacted positively to economic data that came out earlier in the morning. Dow

MT NewswiresFeb 29 09:27 ET